1. Home
  2. BWAY vs PIM Comparison

BWAY vs PIM Comparison

Compare BWAY & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • PIM
  • Stock Information
  • Founded
  • BWAY 2003
  • PIM 1988
  • Country
  • BWAY Israel
  • PIM United States
  • Employees
  • BWAY N/A
  • PIM N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • PIM Finance Companies
  • Sector
  • BWAY Health Care
  • PIM Finance
  • Exchange
  • BWAY Nasdaq
  • PIM Nasdaq
  • Market Cap
  • BWAY 159.3M
  • PIM 159.3M
  • IPO Year
  • BWAY 2019
  • PIM N/A
  • Fundamental
  • Price
  • BWAY $10.00
  • PIM $3.23
  • Analyst Decision
  • BWAY Strong Buy
  • PIM
  • Analyst Count
  • BWAY 3
  • PIM 0
  • Target Price
  • BWAY $13.17
  • PIM N/A
  • AVG Volume (30 Days)
  • BWAY 88.8K
  • PIM 57.5K
  • Earning Date
  • BWAY 11-12-2024
  • PIM 01-01-0001
  • Dividend Yield
  • BWAY N/A
  • PIM 8.28%
  • EPS Growth
  • BWAY N/A
  • PIM N/A
  • EPS
  • BWAY 0.04
  • PIM 0.05
  • Revenue
  • BWAY $38,631,000.00
  • PIM N/A
  • Revenue This Year
  • BWAY $378.91
  • PIM N/A
  • Revenue Next Year
  • BWAY $20.27
  • PIM N/A
  • P/E Ratio
  • BWAY $122.14
  • PIM $63.80
  • Revenue Growth
  • BWAY 34.19
  • PIM N/A
  • 52 Week Low
  • BWAY $4.61
  • PIM $2.90
  • 52 Week High
  • BWAY $10.98
  • PIM $3.28
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 53.76
  • PIM 36.83
  • Support Level
  • BWAY $8.96
  • PIM $3.21
  • Resistance Level
  • BWAY $10.27
  • PIM $3.31
  • Average True Range (ATR)
  • BWAY 0.62
  • PIM 0.03
  • MACD
  • BWAY -0.06
  • PIM -0.00
  • Stochastic Oscillator
  • BWAY 57.76
  • PIM 15.00

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About PIM Putnam Master Intermediate Income Trust

Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.

Share on Social Networks: